United States — Committee on Foreign Investment in the United States

Impact: The United States — Committee on Foreign Investment in the United States is the federal body responsible for scrutinizing foreign transactions for security vulnerabilities and identified national security risks in the HieFo Corporation and Oracle Corporation transaction.

Impact: CFIUS rejected FastWave's filing, effectively siding with Grand Pharmaceutical Group, citing 'material misstatements' by FastWave. This decision has raised concerns about the committee's process and potential influence from lobbyists.

Impact: The United States — Committee on Foreign Investment in the United States failed to reach a consensus on the acquisition, referring the final decision to Joe Biden.

Impact: The United States — Committee on Foreign Investment in the United States failed to reach a consensus on the national security risks of the deal, sending a report to Joe Biden for a final decision. This committee's review process was a key step in the eventual blocking of the acquisition.

Impact: The United States — Committee on Foreign Investment in the United States identified a national security risk in the deal, leading to the presidential order.

Impact: The United States — Committee on Foreign Investment in the United States conducted a national security review of Cerebras Systems' partnership with G42, which was eventually cleared.

Impact: The United States — Committee on Foreign Investment in the United States provided regulatory clearance for the transaction, ensuring national security interests were addressed.